CPM
EVH icon

Corre Partners Management’s Evolent Health EVH Stock Holding History

Corre Partners Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,412
Closed -$399K – 8
2021
Q4 		$399K Buy
+14,412
New +$413K 0.16% 10

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Corre Partners Management's EVH Position: Q1 2022 in Review

Corre Partners Management sold out of Evolent Health (EVH) in Q1 2022, closing a stake of 14,412 shares — an estimated $399K sold.

Corre Partners Management first reported a position in EVH in Q4 2021 and held it in 1 quarter. The position peaked at $399K in Q4 2021. 218 funds tracked by Wall St. Rank hold EVH as of Q1 2022.

  • Corre Partners Management reported no remaining Evolent Health position as of Q1 2022 after selling out during the quarter.
  • Corre Partners Management sold 14,412 Evolent Health shares in Q1 2022, an estimated $399K.
  • Corre Partners Management first reported a position in Evolent Health in Q4 2021 and held it in 1 quarter.
  • Corre Partners Management's Evolent Health position peaked at $399K in Q4 2021.
  • 218 funds tracked by Wall St. Rank held Evolent Health as of Q1 2022.

Based on Corre Partners Management's 13F filing for Q1 2022, filed 13 May 2022.